Developing the EPA Guidance of Pharmacological Treatment of Schizophrenia – Results of a Delphi process

Peter Falkai*: Affiliation:
Department of Psychiatry and Psychotherapy, LMU University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany DZPG (German Center for Mental Health), partner site München/Augsburg, LMU Munich, Germany
Elias Wagner: Affiliation:
Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Evidence-based psychiatry and psychotherapy, Faculty of Medicine, University of Augsburg, Augsburg, German
Miriam John: Affiliation:
Department of Psychiatry and Psychotherapy, LMU University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany
Vladislav Yakimov: Affiliation:
Department of Psychiatry and Psychotherapy, LMU University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany International Max Planck Research School for Translational Psychiatry (IMPRS-TP), 80804 Munich, Germany
Silvana Galderisi: Affiliation:
Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
Istvan Bitter: Affiliation:
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
Geert Dom: Affiliation:
Collaborative Antwerp Psychiatric Research Institute, Wilrijk, Belgium
Andrea Schmitt: Affiliation:
Department of Psychiatry and Psychotherapy, LMU University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany
Wolfgang Gaebel: Affiliation:
Department of Psychiatry and Psychotherapy, Heinrich Heine University, Düsseldorf, Germany
Bernardo Carpiniello: Affiliation:
Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
Alkomiet Hasan: Affiliation:
Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, University of Augsburg, Augsburg, Germany. DZPG (German Center for Mental Health), partner site München/Augsburg, Augsburg, Germany
*: Corresponding author: Peter Falkai, Department of Psychiatry, Ludwig Maximilians University Munich, Nussbaumstr. 7, 80336 Munich, Germany; phone: 0049-89-440055501; mail: peter.falkai@med.uni-muenchen.de

Article contents

Abstract

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Viewpoint
Information: European Psychiatry , Accepted manuscript , pp. 1 - 24

DOI: https://doi.org/10.1192/j.eurpsy.2024.1794 [Opens in a new window]
Creative Commons: This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.